These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug targets in the voltage-gated calcium channel family: why some are and some are not. Triggle DJ Assay Drug Dev Technol; 2003 Oct; 1(5):719-33. PubMed ID: 15090244 [TBL] [Abstract][Full Text] [Related]
3. Calcium, calcium channels, and calcium channel antagonists. Triggle DJ Can J Physiol Pharmacol; 1990 Nov; 68(11):1474-81. PubMed ID: 1962736 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels. Orth SR; Nobiling R; Bönisch S; Ritz E Kidney Int; 1996 Mar; 49(3):868-79. PubMed ID: 8648932 [TBL] [Abstract][Full Text] [Related]
6. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists. Zahradníková A; Minarovic I; Zahradník I J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903 [TBL] [Abstract][Full Text] [Related]
7. Vascular effects of calcium channel antagonists: new evidence. Richard S Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057 [TBL] [Abstract][Full Text] [Related]
8. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium. Melena J; Osborne NN Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667 [TBL] [Abstract][Full Text] [Related]
10. New advances in the field of calcium channel antagonists: cardiovascular effects and structure-activity relationships. Romero M; Sánchez I; Pujol MD Curr Med Chem Cardiovasc Hematol Agents; 2003 Jun; 1(2):113-41. PubMed ID: 15320693 [TBL] [Abstract][Full Text] [Related]
11. L-type calcium channels mediate mechanically induced bone formation in vivo. Li J; Duncan RL; Burr DB; Turner CH J Bone Miner Res; 2002 Oct; 17(10):1795-800. PubMed ID: 12369783 [TBL] [Abstract][Full Text] [Related]
12. Synthetic organic ligands active at voltage-gated calcium channels. Triggle DJ; Hawthorn M; Gopalakrishnan M; Minarini A; Avery S; Rutledge A; Bangalore R; Zheng W Ann N Y Acad Sci; 1991; 635():123-38. PubMed ID: 1660234 [No Abstract] [Full Text] [Related]
16. The effects of L type calcium channels on the electroencephalogram recordings in WAG/RIJ rat model of absence epilepsy. Durmus N; Kaya T; Gültürk S; Demir T; Parlak M; Altun A Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1149-54. PubMed ID: 23690182 [TBL] [Abstract][Full Text] [Related]
18. Ligand-activated signal transduction in the 2-cell embryo. Lu DP; Li Y; Bathgate R; Day M; O'Neill C Biol Reprod; 2003 Jul; 69(1):106-16. PubMed ID: 12606379 [TBL] [Abstract][Full Text] [Related]
19. Identification of a sphingosine-sensitive Ca2+ channel in the plasma membrane of Leishmania mexicana. Benaim G; García-Marchán Y; Reyes C; Uzcanga G; Figarella K Biochem Biophys Res Commun; 2013 Jan; 430(3):1091-6. PubMed ID: 23261440 [TBL] [Abstract][Full Text] [Related]
20. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle. Ishii K; Taira N; Yanagisawa T Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]